Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats

Hypertension

Volumn 30, Issue 4, 1997, Pages 859-867

  Nyui, Nobuo ^b   Tamura, Kouichi ^b   Yamaguchi, Satoshi ^b   Nakamaru, Masashi ^b   Ishigami, Tomoaki ^b   Yabana, Machiko ^b   Kihara, Minoru ^b   Ochiai, Hisao ^b   Miyazaki, Naomichi ^b   Umemura, Satoshi ^a   Ishii, Masao ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

Angiotensinogen; Lipopolysaccharide; Rats, inbred SHR; Renin angiotensin system; RNA, messenger; Tumor necrosis factor

Indexed keywords

ANGIOTENSINOGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030800656     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.859     Document Type: Article

References (61)

1. Clauser E, Bouhnik J, Coezy E, Corvol P, Menard J. Synthesis and release of immunoreactive angiotensinogen by rat liver slices. Endocrinology. 1983;112:1188-1193.
2. Peter HJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol. 1985;248:F621-F630.
3. Klett C, Komischke K, Munter K, Hackenthal E. Secretion of angiotensinogen and acute phase proteins during various forms of acute inflammatory injury. J Hypertens. 1987;5:S19-S21.
4. Iwao H, Kimura S, Fukui K, Nakamura A, Tamaki T, Ohkuho H, Nakanishi S, Abe Y. Elevated angiotensinogen mRNA levels in rat liver by nephrectomy. Am J Physiol. 1990;258:E413-E417.
5. Klett C, Nobiling R, Gierschik P, Hackenthal E. Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J Biol Chem. 1993;268:25095-25107.
6. Sernia C, Clements JA, Funder JW. Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxine. Mol Cell Endocrinol. 1989;61:147-156.
7. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986;78:31-39.
8. Ron D, Brasier AR, Wright KA, Habener JF. The permissive role of glucocorticoids on IL-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol. 1990;10:4389-4395.
9. Dzau VJ, Herrmann HC. Hormonal control of angiotensinogen production. Life Sci. 1982;30:577-584.
10. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
11. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
12. Lo M, Julien C, Michel JB, Vincent M, Cerutti C, Gomez-Sanchez CE, Sarrard J. Antirenin immunization versus angiotensin converting enzyme inhibition in rats. Hypertension. 1990;16:80-88.
13. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
14. Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in SHR. Hypertension. 1984;6:682-688.
15. Lindpaintner K, Niedermaier N, Drexler H, Ganten D. Left ventricular remodelling after myocardial infarction. J Cardiovasc Pharmacol. 1992;20(suppl 1):S41-S47.
16. Pratt RE, Zou WM, Naftilan AJ, Ingelfinger JR, Dzau VJ. Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat. Am J Physiol. 1989;256:F469-F474.
17. Fukamizu A, Takahashi S, Seo MS, Tada M, Tanimoto K, Uehara S, Murakami K. Structure and expression of the human angiotensinogen gene. J Biol Chem. 1990;265:7576-7582.
18. Brasier AR, Ron D, Tate JE, Habener JF. Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression. Mol Endocrinol. 1989;3:1022-1034.
19. Tamura K, Tanimoto K, Takahashi S, Sagara M, Fukamizu A, Murakami K. Structure and expression of the mouse angiotensinogen gene. Jpn Heart J. 1992;33:113-124.
20. Clauston WM, Lyons IG, Richards RI. Tissue specific and hormonal regulation of angiotensinogen minigenes in transgenic mice. EMBO J. 1989;8:3337-3343.
21. Takahashi S, Fukamizu A, Hasegawa T, Yokoyama M, Nomura T, Katsuki M, Murakami K. Expression of the human angiotensinogen gene in transgenic mice and transfected cells. Biochem Biophys Res Commun. 1991;180:1103-1109.
22. Tamura K, Umemura S, Ishii M, Tanimoto K, Murakami K, Fukamizu A. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest. 1994;93: 1370-1379.
23. Ron D, Braiser AR, Wright KA, Tate JE, Habener JF. An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol Cell Biol. 1990;10:1023-1032.
24. Dzielak DJ. Immune mechanisms in experimental and essential hypertension. Am J Physiol. 1991;260:R459-R467.
25. Khraibi AA. Association between disturbances in the immune system and hypertension. Am J Hypertens. 1991;4:635-641.
26. Takeichi N, Suzuki K, Okayasu T, Kobayashi H. Immunological depression in spontaneously hypertensive rats. Clin Exp Immunol. 1980;40:120-126.
27. Takeichi N, Suzuki K, Kobayashi H. Characterization of immunological depression in spontaneously hypertensive rats. Eur J Immunol. 1981;11:483-487.
28. Takeichi N, Ba D, Kobayashi H. Natural cytotoxic autoantibody against thymocytes in spontaneously hypertensive rats. Cell Immunol. 1981;60:181-190.
29. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol. 1982;128:1211-1216.
30. Yamakawa T, Tanaka S, Tamura K, Isoda F, Ukawa K, Yamakura Y, Takanashi Y, Kiuchi Y, Umemura S, Ishii M, Sekihara H. Wistar fatty rat is obese and spontaneously hypertensive. Hypertension. 1995;25:146-150.
31. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994;23:422-427.
32. Shimamoto K, Ishida H, Nakahashi Y, Nishitani T, Hosoda S, Yokoyama T, Tanaka S, Iimura O. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J. 1984;48: 1228-1235.
33. Tamura K, Tanimoto K, Ishii M, Murakami K, Fukamizu A. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation. J Biol Chem. 1993;268:15024-15032.
34. Tamura K, Umemura S, Yamaguchi S, Iwamoto T, Kobayashi S, Fukamizu A, Murakami K, Ishii M. Mechanism of cAMP regulation of renin gene transcription by proximal promoter. J Clin Invest. 1994;94:1959-1967.
35. Chirgwin JM, Fryzhyia AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in nuclease. Biochemistry. 1979;18:5294-5299.
36. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA. 1983;80:2196-2200.
37. Yamakawa T, Tanaka S, Yamakawa Y, Isoda F, Kawamoto S, Fukushima J, Minami M, Okuda K, Sekihara H. Genetic control of in vivo tumor necrosis factor production in mice. Clin Immunol Immunopathol. 1996;62:258-263.
38. Tso JY, Sun X-H, Kao T, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
39. Kageyama R, Ohkubo H, Nakanishi S. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem Biophys Res Commun. 1985;129:826-832.
40. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 1995;95: 2409-2415.
41. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by Rel A transactivator. Hypertension. 1996;27:1009-1017.
42. Tamura K, Umemura S, Nyui N, Yamakawa T, Yamaguchi S, Ishigami T, Tanaka S, Tanimoto K, Takagi N, Sekihara H, Murakami K, Ishii M. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension. 1996;27:1216-1223.
43. Fernandes-Alfonso MS, Kreuz R, Zeh K, Liu Y, Ganten D, Paul M. Differential regulation of vascular angiotensin I-converting enzyme in hypertension. Hypertension. 1994;24:280-286.
44. Okamoto H, Ohashi Y, Itoh N. Involvement of leukocyte and glucocorticoid in the acute-phase response of angiotensinogen. Biochem Biophys Res Commun. 1987;145:1225-1230.
45. Lodwick D, Kaiser MA, Harris J, Cumin F, Vincent M, Samami NJ. Analysis of the role of angiotensinogen in spontaneous hypertension. Hypertension. 1995;25:1245-1251.
46. Deschepper CF, Reudelhuber TL. Rat angiotensinogen is secreted only constitutively when transfected into AtT-20 cells. Hypertension. 1990;16:147-153.
47. 3H-captopril: localization to a striatonigral pathway. Proc Natl Acad Sci U S A. 1984;81:1599-1603.
48. Deschepper CF, Dallman MF. The stimulation of liver angiotensinogen by glucocorticoids depends on the type of steroid and its mode of administration. Endocrinology. 1992;131:2371-2377.
49. Okamoto H, Hatta A, Itoh N, Ohashi Y, Arakawa K, Nakanishi S. Acute phase responses of plasma angiotensinogen and T-kininogen in rats. Biochem Pharmacol. 1987;36:3069-3073.
50. Takano M, Yokoyama K, Yayama K, Itoh N, Okamoto H. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochem Pharmacol. 1993;45: 201-206.
51. Soden M, Klett C, Hasmann T, Hackenthal E. Angiotensinogen: an acute-phase protein? Hypertension. 1994;23(suppl I):I-126-I-130.
52. Hara-Kuge S, Amano F, Nishijima M, Akamatau Y. Isolation of a lipopolysaccharide (LPS)-resistant mutant, with defective LPS binding, of cultured macrophage-like cells. J Biol Chem. 1990;265: 6606-6610.
53. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431-1433.
54. Itoh N, Matsuda T, Ohtani R, Okamoto H. Angiotensinogen production by rat hepatoma cells is stimulated by B cell stimulatory factor 2/interleukin-6. Fed Eur Biochem. 1989;244:6-10.
55. Ron D, Brasier AR, Wright KA, Tate JE, Habener JF. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol. 1990;10:4389-4395.
56. Braiser AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27(part 2):465-475.
57. Tamura K, Umemura S, Iwamoto T, Yamaguchi S, Kobayashi S, Takeda K, Tokita Y, Takagi N, Murakami K, Fukamizu A, Ishii M. Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension. 1994;23:364-368.
58. Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 1992;19:339-344.
59. Ron D, Braiser AR, McGehee RE Jr, Habener JF. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). J Clin Invest. 1992;89:223-233.
60. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-1321.
61. Green A, Dobias SB, Walters DJA, Braiser AR. Tumor necrosis factor increases the role of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology. 1994;134:2581-2588.